AVROBIO, Inc. Gains 69.01%
AVROBIO, Inc. (AVRO:NASDAQ) shot up at $1.31, a gain of 69%. On Mon, May 22, 2023, AVRO:NASDAQ touched a New 2-Week High of $1.31. The stock got featured on our News Catalysts scanner on Mon, May 22, 2023 at 07:15 AM in the 'AGREEMENT' category. From Mon, May 08, 2023, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Mon, May 22, 2023 at $1.7 with a volume of 85M+.
About AVROBIO, Inc. (AVRO:NASDAQ)
Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
Top 10 Gainers:
- Calithera Biosciences, Inc. (CALA:NASDAQ), 936.67%
- Microbot Medical Inc. (MBOT:NASDAQ), 159.35%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 117.51%
- Greenhill & Co., Inc. (GHL:NYSE), 116.22%
- D-Wave Quantum Inc. (QBTS:NYSE), 110.7%
- AVROBIO, Inc. (AVRO:NASDAQ), 69.01%
- Verde Clean Fuels Cl A (VGAS:NASDAQ), 54.8%
- Peraso Inc. (PRSO:NASDAQ), 53.38%
- Rigetti Computing Inc. (RGTI:NASDAQ), 44.87%
- VectivBio Holding AG (VECT:NASDAQ), 38.61%